131 related articles for article (PubMed ID: 36507828)
41. Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region.
Esposito G; Dilaghi E; Cazzato M; Pilozzi E; Conti L; Carabotti M; Di Giulio E; Annibale B; Lahner E
Dig Liver Dis; 2021 Apr; 53(4):467-473. PubMed ID: 33199230
[TBL] [Abstract][Full Text] [Related]
42. Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment.
Varbanova M; Wex T; Jechorek D; Röhl FW; Langner C; Selgrad M; Malfertheiner P
J Clin Pathol; 2016 Jan; 69(1):19-25. PubMed ID: 26163538
[TBL] [Abstract][Full Text] [Related]
43. The Impact of Proton Pump Inhibitors on the Development of Gastric Neoplastic Lesions in Patients With Autoimmune Atrophic Gastritis.
Dilaghi E; Bellisario M; Esposito G; Carabotti M; Annibale B; Lahner E
Front Immunol; 2022; 13():910077. PubMed ID: 35935934
[TBL] [Abstract][Full Text] [Related]
44. Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer.
Shin WG; Kim HU; Song HJ; Hong SJ; Shim KN; Sung IK; Kim JG;
Dig Dis Sci; 2012 Mar; 57(3):746-52. PubMed ID: 21984437
[TBL] [Abstract][Full Text] [Related]
45. High Salt Intake Is Associated with Atrophic Gastritis with Intestinal Metaplasia.
Song JH; Kim YS; Heo NJ; Lim JH; Yang SY; Chung GE; Kim JS
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1133-1138. PubMed ID: 28341758
[No Abstract] [Full Text] [Related]
46. [Why is it important to detect atrophic gastritis and gastric intestinal metaplasia? What is the proper way to do it?].
Sarem M; Corti R
Rev Gastroenterol Peru; 2020; 40(3):260-266. PubMed ID: 33181813
[TBL] [Abstract][Full Text] [Related]
47. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis.
Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
Scand J Gastroenterol; 2019 Feb; 54(2):145-151. PubMed ID: 30700174
[TBL] [Abstract][Full Text] [Related]
48. Screening, Monitoring, and Treatment of Precancerous Atrophic Gastritis in the Prospective Study for Seven Years.
Kotelevets SM; Chekh SA
Asian Pac J Cancer Prev; 2020 Feb; 21(2):331-336. PubMed ID: 32102507
[TBL] [Abstract][Full Text] [Related]
49. Optical enhancement imaging versus acetic acid for detecting gastric intestinal metaplasia: A randomized, comparative trial.
Ji R; Liu J; Zhang MM; Li YY; Zuo XL; Wang X; Li YQ
Dig Liver Dis; 2020 Jun; 52(6):651-657. PubMed ID: 32265143
[TBL] [Abstract][Full Text] [Related]
50. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
51. Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up.
Zhang L; Liu Y; You P; Feng G
Scand J Gastroenterol; 2018; 53(7):843-848. PubMed ID: 29911441
[TBL] [Abstract][Full Text] [Related]
52. Biopsy strategies for endoscopic screening of pre-malignant gastric lesions.
Zhang M; Liu S; Hu Y; Bao HB; Meng LN; Wang XT; Xu Y; Zhao J; Lu B
Sci Rep; 2019 Oct; 9(1):14909. PubMed ID: 31624309
[TBL] [Abstract][Full Text] [Related]
53. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer.
den Hoed CM; Holster IL; Capelle LG; de Vries AC; den Hartog B; Ter Borg F; Biermann K; Kuipers EJ
Endoscopy; 2013; 45(4):249-56. PubMed ID: 23533073
[TBL] [Abstract][Full Text] [Related]
54. Secondary prevention of gastric cancer.
Rugge M
Gut; 2007 Dec; 56(12):1646-7. PubMed ID: 17998318
[TBL] [Abstract][Full Text] [Related]
55. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis.
Petersson F; Borch K; Franzén LE
Scand J Gastroenterol; 2002 Mar; 37(3):262-6. PubMed ID: 11916187
[TBL] [Abstract][Full Text] [Related]
57. Ethnicity Is an Important Consideration in Screening for Gastric Intestinal Metaplasia.
Kligman E; Ali H; Chen E; Peng F; Szafron D; Staggers K; Tan MC; Patel K; Othman MO
Dig Dis Sci; 2022 Sep; 67(9):4509-4517. PubMed ID: 34981309
[TBL] [Abstract][Full Text] [Related]
58. Incomplete intestinal metaplasia as an indicator for early detection of gastric carcinoma in the events of helicobacter pylori positive chronic atrophic gastritis.
Vukobrat-Bijedić Z; Radović S; Husić-Selimović A; Gornjaković S
Bosn J Basic Med Sci; 2006 Nov; 6(4):48-53. PubMed ID: 17177650
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic Accuracy of EndoFaster® and Narrow-Band Imaging Endoscopy in Patients with Impaired Gastric Acid Secretion: A Real-Time Prospective Study.
Cazzato M; Esposito G; Galli G; Pilozzi E; Lahner E; Corleto VD; Zullo A; Di Giulio E; Annibale B
Gastroenterol Res Pract; 2021; 2021():6616334. PubMed ID: 33824659
[TBL] [Abstract][Full Text] [Related]
60. [Surveillance of patients with gastric intestinal metaplasia and dysplasia].
Vilkin A; Half B; Moshkowitz M; Kariv R; Levi Z
Harefuah; 2011 Mar; 150(3):266-8, 302. PubMed ID: 21574363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
